Calithera Biosciences Inc (CALA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CALA Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Calithera Biosciences Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent25.45
Cash & Short-term Investments25.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.17
Total Current Assets26.62
Equipment/Property/Plant Net0.43
Long-term investments0.27
Other Assets, Noncurrent0.27
Operating Lease Right Of Use Asset1.35
Total Assets28.68
Liabilities
Accounts Payable, Current AC0.73
Accrued Liabilities And Other Liabilities6.66
Total Current Liabilities7.39
Total Long-term Debt0.00
Other liabilities, Noncurrent0.89
Operating Lease Liability Noncurrent0.14
Total Liabilities8.28
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock510.67
Retained Earnings / Accumulated Deficit-512.62
Other Equity0.00
Common Stockholder's Equity-1.95
Preferred Stockholder's Equity22.34
Non-controlling interests & other0.00
Total Stockholder's Equity20.39
Liabilities & Stockholder's Equity28.68
4 historic quarters locked

Sign in to unlock the full Calithera Biosciences Inc balance sheet history.

About Calithera Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-011047

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.